Is medical therapy effective for regional lymphadenitis following BCG vaccination? 1987

S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
Department of Pediatrics, Sosyal Sigortalar Tepecik Teaching Hospital Yenişehir, Izmir, Turkey.

We describe 120 patients with regional lymphadenitis following intradermal BCG vaccination. Seventy-eight of the patients were given medical therapy to prevent drainage and suppuration, and 42 patients were followed up without such treatment. The medical therapy group is divided into three subgroups: 36 were given erythromycin stearate, 21 isoniazid, and 21 isoniazid plus rifampin. No statistical difference in the incidence of spontaneous drainage and suppuration was found between the "no therapy" and the "medical therapy" groups. No significant superiority of any specific therapy was shown. If lymphadenitis develops rapidly (in two months), the incidence of spontaneous drainage and suppuration is significantly higher than in patients with slowly developing lesions. Total surgical excision is recommended to prevent spontaneous drainage and chronic suppuration in these rapidly evolving instances.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008199 Lymphadenitis Inflammation of the lymph nodes. Adenitis,Adenitides,Lymphadenitides
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
January 1991, Infection,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
April 1996, Pediatric surgery international,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
August 1951, Polski tygodnik lekarski,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
November 1983, Archives of disease in childhood,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
May 1978, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
September 1977, Deutsche medizinische Wochenschrift (1946),
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
September 1981, Tubercle,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
January 1955, Bulletin of the World Health Organization,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
June 1954, Gyermekgyogyaszat : az Orvosegeszsegugyi Szakszervezet Gyermekorvos Szakcsoportjanak folyoirata = Pediatriia,
S Caglayan, and O Yegin, and K Kayran, and N Timocin, and E Kasirga, and M Gun
December 1982, Archives of disease in childhood,
Copied contents to your clipboard!